[Oct 24, 2021] Passing Key To Getting RAC-US Certified Exam Engine PDF
RAC-US Exam Dumps Pass with Updated Oct-2021 Tests Dumps
NEW QUESTION 19
A drug product presents degradation during the manufacturing process. In addition to the amount, what information should be provided FIRST in order to use API overage?
- A. Formulation
- B. Specification
- C. Property
- D. Justification
Answer: D
NEW QUESTION 20
What is the LAST stage in the development of a quality risk management process for a medical device?
- A. Risk acceptance
- B. Risk reduction
- C. Risk evaluation
- D. Risk analysis
Answer: A
NEW QUESTION 21
Which of the following is NOT required to be included in a marketing application?
- A. Evidence of fee payment
- B. Administrative forms
- C. Quality, safety, and efficacy Information
- D. Final printed label
Answer: A
NEW QUESTION 22
In which section of the ICH Common Technical Document will the overview of clinical data appear?
- A. Module 2
- B. Module 1
- C. Module 4
- D. Module 3
Answer: A
NEW QUESTION 23
A request was received from a regulatory authority asking the company to conduct product testing in compliance with a newly issued regulation.
What should be done. What action should the company take FIRST?
- A. Initiate testing immediately to ensure compliance.
- B. Contact the regulatory authority that issued this request and discuss the requirement.
- C. Send a letter back to the regulatory authority indicating why the regulation does not apply to the product.
- D. Consult with colleagues about the request.
Answer: B
NEW QUESTION 24
GHTF recommends that the medical device manufacturer define the scope of the clinical evaluation based on which of the following?
- A. Risk analysis
- B. Instructions for use
- C. Product literature
- D. Essential principles
Answer: A
NEW QUESTION 25
Company X and Company Y both have products for the treatment of rare genetic diseases.
Company X would like to acquire Company Y but does not know enough about Company Y to make an offer.
What is the MOST appropriate approach that Company X should take to acquire more information about Company Y?
- A. Recruit a professional to gather confidential intelligence on Company Y.
- B. Request the needed information from the Board of Directors of Company Y.
- C. Perform a thorough library search to gather detailed information on Company Y.
- D. Enter into an agreement with Company Y to perform due diligence.
Answer: D
NEW QUESTION 26
A superiority advertising claim for a product versus its competitor's product can only be made under which of the following circumstances?
- A. Government survey data indicate the product is superior.
- B. In vitro studies show the product to be superior.
- C. Results of adequate, well-controlled comparative clinical trial show the product is superior.
- D. Results of a three-year, post-market patient survey indicate the product is superior.
Answer: C
NEW QUESTION 27
According to WHO, what are the temperature and humidity conditions for a Zone IVb long- term stability study?
- A. 25: C and 60% RH
- B. 30c C and 65% RH
- C. 30 C and 35% RH
- D. 30: C and 75% RH
Answer: D
NEW QUESTION 28
The requirements for document control are located in which of the following documents?
- A. WHO guidelines
- B. ISO 13485
- C. ICH guidelines
- D. IEC 60601
Answer: B
NEW QUESTION 29
In order to develop a global drug product, what is the MOST important environmental characteristic to consider in the country of intended use?
- A. Product stability
- B. Product requirements
- C. Product formulation
- D. Product registration
Answer: A
NEW QUESTION 30
At the last internal audit, a regulatory affairs professional identified a need for a corrective action for the manufacturing process. Which of the following stakeholders should be notified FIRST?
- A. Clinical affairs
- B. Regulatory agency
- C. Quality assurance
- D. Quality improvement
Answer: C
NEW QUESTION 31
A regulation change is imminent and may require further non-clinical testing on a product currently in Phase III clinical trials. What is the most appropriate action to take FIRST?
- A. Obtain a copy of the proposed regulation and analyze the impact.
- B. Consult with the company's legal department regarding options.
- C. Inform the company's senior management and arrange an emergency meeting
- D. Arrange for additional testing of the product at the testing facility.
Answer: A
NEW QUESTION 32
According to ICH, how many stability time points are normally required to establish a two- year shelf life for a product?
- A. 0
- B. 1
- C. 2
- D. 3
Answer: B
NEW QUESTION 33
In preparation for the development of a new line of products, a regulatory affairs professional is asked to prepare a short presentation for senior management. Which of the following topics is MOST important to cover?
- A. Potential clinical sites for the Phase III clinical trial
- B. Capacity of the manufacturing facilities to fully produce the new product
- C. Previous actions taken by regulatory authorities on similar products
- D. Regulatory requirements for labeling and packaging
Answer: C
NEW QUESTION 34
During a regulatory authority inspection of a manufacturing site, the inspector observes that one of the medicinal products manufactured at the site is not GMP compliant. The product
Is distributed globally.
Which of the following is the most appropriate action to take FIRST?
- A. Send a "Dear Dr." letter to customers.
- B. Withdraw the affected product from the markets.
- C. Assess the potential safety risk.
- D. Notify the global regulatory authorities.
Answer: D
NEW QUESTION 35
A materials supplier informs a company that it intends to stop supplying a material critical to the manufacture of the company's products. What action should the company take FIRST?
- A. Complete a gap analysis to identify options.
- B. Review the company's existing Quality Management System
- C. Reformulate the products with a replacement material.
- D. Qualify another supplier and execute a supplier agreement.
Answer: D
NEW QUESTION 36
A company is developing a new line of products in an area that is new to the company.
What is the BEST approach?
- A. Summarize regulatory documents and history and provide the information to the management team.
- B. Ask the trade association representative to provide an overview of the new product area to the marketing team.
- C. Obtain competitor research and provide the information to the management team.
- D. Obtain regulatory documents and history and provide the information to R&D.
Answer: A
NEW QUESTION 37
......
RAC-US exam questions for practice in 2021 Updated 100 Questions: https://www.exam4labs.com/RAC-US-practice-torrent.html
Updated Premium RAC-US Exam Engine pdf: https://drive.google.com/open?id=1wCBhPe75QgVcb_vnx2jfv4Suxoxea-f0